Investigational Site Number 643008

Novosibirsk 630087

0 studies enrolling now · 3 studies all time

What they study most

Relapsing-remitting Multiple Sclerosis, Venous Thromboembolism

Studies at this site

• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early
• Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 — Stopped early
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed